↓ Skip to main content

Vaccination demonstration zone successfully controls rabies in Guangxi Province, China

Overview of attention for article published in BMC Infectious Diseases, August 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vaccination demonstration zone successfully controls rabies in Guangxi Province, China
Published in
BMC Infectious Diseases, August 2018
DOI 10.1186/s12879-018-3301-8
Pubmed ID
Authors

Xian-Kai Wei, Yi Xiong, Xiao-Ning Li, Min Zheng, Yan Pan, Xiao-Xia He, Jing-Jing Liang, Cheng Liu, Yi-Zhi Zhong, Lian-Bin Zou, Lie-Feng Zheng, Jian-Gang Guo, Chang-Ting Li, Sheng-Bin Huang, Jia-Zhong Gan, Zhen-Mu Meng, Jian Yang, Hai-Bo Tang, Qi Liu, Ting Rong Luo

Abstract

Guangxi is the province most seriously affected by rabies virus (RABV) in China. Those most affected by RABV each year are people in rural areas, where dogs are the main cause of human infection with the virus. In this study, we established a rabies vaccination demonstration program that included eradication, core, and peripheral areas. This program was implemented for 9 years and comprised three stages: 12 counties in the first stage (2008-2010), 21 counties in the second stage (2011-2013), and then extending to all counties of Guangxi Province in the third stage (2014-2016). The program included a dog vaccination campaign, surveillance of clinically healthy dogs who may be potential RABV carriers, monitoring anti-RABV antibody titers in vaccinated dogs, and compiling and reporting statistics of human rabies cases. The target effectiveness was achieved in the eradication, core, and peripheral areas in all three stages. The vaccination demonstration program successfully promoted RABV vaccination of domestic dogs throughout Guangxi Province by drawing upon the experience gained at key points. Compared with a vaccination coverage rate of 39.42-46.85% in Guangxi Province overall during 2003-2007, this rate gradually increased to 48.98-52.67% in 2008-2010, 60.24-69.67% in 2011-2013, and 70.09-71.53% in 2014-2016, thereby meeting World Health Organization requirements. The total cases of human rabies in the province decreased from 602 in 2004 to 41 cases in 2017. The present pilot vaccination program obviously increased the rabies vaccination and seroconversion rates, and effectively reduced the spread of rabies from dogs to humans as well as the number of human rabies cases, thus successfully controlling rabies in Guangxi.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 24%
Researcher 5 15%
Lecturer 2 6%
Student > Ph. D. Student 2 6%
Professor 1 3%
Other 2 6%
Unknown 13 39%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 5 15%
Immunology and Microbiology 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Nursing and Health Professions 2 6%
Agricultural and Biological Sciences 2 6%
Other 6 18%
Unknown 13 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2023.
All research outputs
#15,034,158
of 23,885,338 outputs
Outputs from BMC Infectious Diseases
#4,012
of 8,002 outputs
Outputs of similar age
#189,834
of 333,962 outputs
Outputs of similar age from BMC Infectious Diseases
#74
of 171 outputs
Altmetric has tracked 23,885,338 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,002 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,962 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 171 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.